Silverback Therapeutics plans merger with San Diego biotech

The move comes months after Seattle-based Silverback shuttered its oncology program. The combined company will focus on an epinephrine nasal spray called Neffy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.